Date published: 2025-12-19

00800 4573 8000

SCBT Portrait Logo
Seach Input

DEAH-box RNA-dependent NTPase (DHX) Inhibitoren

The DEAH-box family of RNA-dependent NTPases (DHX) plays a crucial role in RNA metabolism, including processes such as splicing, ribosome biogenesis, and mRNA export from the nucleus. These proteins act as molecular motors that harness the energy from nucleotide hydrolysis to unwind or remodel RNA and RNA-protein complexes. The DHX proteins generally contain conserved motifs that are essential for ATP binding and hydrolysis, as well as RNA binding and unwinding. Through their ATPase and helicase activities, DHX proteins are able to dynamically regulate the structure and function of various RNA molecules and complexes, thereby influencing diverse cellular processes.

The class of molecules known as DEAH-box RNA-dependent NTPase (DHX) Inhibitors is specifically designed to modulate the activity of the DHX family of proteins, which are central to RNA metabolism in the cell. These inhibitors typically target the ATPase or helicase domains of DHX proteins, as these are the functional cores responsible for nucleotide binding, hydrolysis, and the subsequent RNA remodeling activities. Some inhibitors may act by binding directly to the ATPase pocket, thereby ATP from binding and disabling the enzyme's activity. Others may bind to regions of the protein that are essential for RNA interaction, therefore making the protein unable to engage with its natural RNA substrates. Some inhibitors are allosteric in nature and can bind to regions other than the active site, causing conformational changes that make the enzyme less effective or completely inactive.

Siehe auch...

Artikel 1 von 10 von insgesamt 11

Anzeigen:

ProduktCAS #Katalog #MengePreisReferenzenBewertung

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K-Inhibitor, der die nachgeschalteten RNA-Verarbeitungswege beeinflusst.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Hemmt die Proteinsynthese und beeinflusst indirekt die RNA-Verarbeitung.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

Hemmt JNK, das eine Rolle beim RNA-Spleißen spielt.

Akt Inhibitor IV

681281-88-9sc-203809
sc-203809A
5 mg
25 mg
$173.00
$695.00
42
(1)

Hemmt Akt, das an der RNA-Verarbeitung beteiligt ist.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK-Inhibitor, der das RNA-Spleißen beeinflussen kann.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

Beeinflusst die Funktion von RNA-Helikasen wie DDX38, indem es DNA-Schäden verursacht.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

Beeinträchtigt die RNA-Helikase-Aktivität indirekt durch Störung des Nukleotidstoffwechsels.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Topoisomerase-II-Inhibitor, der möglicherweise die RNA-Verarbeitung beeinflusst.

2′-Deoxy-2′,2′-difluorocytidine

95058-81-4sc-275523
sc-275523A
1 g
5 g
$56.00
$128.00
(1)

Stört die DNA-Synthese und -Reparatur und wirkt sich auf RNA-Helikasen wie DDX38 aus.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

Topoisomerase-I-Inhibitor, der DNA-Schäden verursacht, die RNA-Helikasen wie DDX38 beeinträchtigen.